Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About ProNAi Therapeutics Inc (DNAI)

Page 1 of 2

It’s a little-known fact that stock performance is not evenly distributed (i.e. you don’t have a 50/50 chance of picking a market-beating stock). In fact, despite the S&P 500 gaining about 5.2% between November 1, 2014 and October 30, 2015, less than 49% of the stocks in the index beat the market during that time. In contrast, the 30 stocks from the index which were the most popular among the investors that we track returned 9.5% during that time and 63% of them beat the market. This shows that while hedge funds get a lot of flak from the mainstream media for their performance, it can be rewarding to follow their moves using the right sets of data. Even then, there is never a fool proof strategy to generating returns, as even the collective wisdom of top hedge funds gets it wrong some times, as in the case of some of their top picks from the index like Micron and Anadarko. The data though, shows that following the collective wisdom of select hedge funds can be a very wise move overall.

ProNAi Therapeutics Inc (NASDAQ:DNAI) has experienced an increase in activity from the world’s largest hedge funds recently. DNAI was in 12 hedge funds’ portfolios at the end of September. There were 0 hedge funds in our database with DNAI holdings at the end of the previous quarter because DNAI did its IPO in July. At the end of this article we will also compare DNAI to other stocks including Quanex Building Products Corporation (NYSE:NX), Tile Shop Hldgs, Inc. (NASDAQ:TTS), and Walter Investment Management Corp (NYSE:WAC) to get a better sense of its popularity.

Follow Pronai Therapeutics Inc (NASDAQ:DNAI)
Trade (NASDAQ:DNAI) Now!

With all of this in mind, let’s take a gander at the recent action encompassing ProNAi Therapeutics Inc (NASDAQ:DNAI).

What does the smart money think about ProNAi Therapeutics Inc (NASDAQ:DNAI)?

When looking at the institutional investors followed by Insider Monkey, OrbiMed Advisors, managed by Samuel Isaly, holds the number one position in ProNAi Therapeutics Inc (NASDAQ:DNAI). OrbiMed Advisors has a $40.8 million position in the stock, comprising 0.4% of its 13F portfolio. Coming in second is Deerfield Management, led by James E. Flynn, holding a $27.7 million position; 1.1% of its 13F portfolio is allocated to the stock. Some other peers that are bullish comprise Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management, Peter Kolchinsky’s RA Capital Management and Kyle Bass’s Hayman Advisors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!